Skip to main content
2025 SECO Annual Congress Main banner
Back

SECO 2025

AOA CE HOURS

COPE-GO

OD FL

OD IL

OD SC

OD TX

AOA-PARA

ABO

NCLE

OPT AZ

OPT FL

OPT GA

OPT KY

OPT NC-SP

OPT NC-CL

OPT NV

OPT SC

OPT TN

62 - Hot Topic Breakfast - The Future of Myopia Management: Perspectives from Leading Experts

Friday, February 28, 2025
8:00 AM – 10:45 AM EST
Location: Georgia World Congress Center, 411/412
CE Hours: 2
Dive into the latest findings from the 2024 National Academies of Sciences, Engineering, and Medicine (NASEM) report on myopia. With 14 months of work and decades of research, this comprehensive report sheds light on the rising incidence of myopia, its pathogenesis, and treatment advancements. Leading optometrists and researchers explore practical applications of the report’s insights and discuss how to translate groundbreaking research into clinical practice. Topics include novel treatments, optical interventions, pharmacological approaches, and more.

Learning Objectives:

Upon conclusion of this activity, attendees will be able to:
  • Understand the key findings of the 2024 NASEM report on myopia and its implications for clinical practice
  • Evaluate emerging and novel myopia treatment options based on the NASEM recommendations
  • Evaluate existing treatment options and new directions for optical, pharmacological, and combination therapies
  • Explore real-world applications of new technologies including FDA-approved contact lenses as well as not-yet FDA-approved spectacle designs available outside US
  • Discuss the micro business aspects of myopia management and how to balance new revenue streams with access to care in private practice
  • Discuss the macro business aspects of myopia management and how the cost-benefit analysis holds up when evaluating lifelong ocular morbidities
Disclosure(s):
Katherine K. Weise, OD, MBA, FAAO: No financial relationships to disclose
Brianna Rhue, OD, FAAO, FSLS: CooperVision: Speaker's Bureau (honoraria or other compensation) (); Dr. Contact Lens: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (); Johnson & Johnson Vision: Speaker's Bureau (honoraria or other compensation) (); OSRX: Advisory Committee/Board Member (); STAAR STUDY: Researcher (grant funding or other support) (); Sydnexis: Advisory Committee/Board Member ()
Debbie Jones, OD: CooperVision: Speaker's Bureau (honoraria or other compensation) (); Essilor: Speaker's Bureau (honoraria or other compensation) (); HOYA: Speaker's Bureau (honoraria or other compensation) (); SIghtglass: Speaker's Bureau (honoraria or other compensation) ()
Safal Khanal, OD: International Myopia Institute: Speaker's Bureau (honoraria or other compensation) (); Meta: Researcher (grant funding or other support) (); National Academies of Sciences, Engineering, and Medicine: Consulting Fees ()